Induction of Cell-mediated Immunity to Autologous Melanoma Cells and Regression of Metastases after Treatment with a Melanoma Cell Vaccine Preceded by Cyclophosphamide

Cancer Research

Volumn 46, Issue 5, 1986, Pages 2572-2577

  Berd, David ^a   Maguire, Henry C ^a   Mastrangelo, Michael J ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; MELANOMA VACCINE; VACCINE;

CANCER; CANCER IMMUNOTHERAPY; CASE REPORT; CELLULAR IMMUNITY; DELAYED HYPERSENSITIVITY; HUMAN; IMMUNOTHERAPY; INTRAVENOUS DRUG ADMINISTRATION; MELANOMA; METASTASIS; PRIORITY JOURNAL; SKIN METASTASIS; SUPPRESSOR CELL; THERAPY;

ADULT; CYCLOPHOSPHAMIDE; FEMALE; HUMAN; HYPERSENSITIVITY, DELAYED; IMMUNITY, CELLULAR; IMMUNOTHERAPY; LIVER NEOPLASMS; MALE; MELANOMA; MIDDLE AGE; NEOPLASM METASTASIS; SUPPORT, U.S. GOV'T, P.H.S.; VACCINES;

EID: 0022597114     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Prehn, R. T., and Main, J. M. Immunity to methylcholanthrene-induced sarcomas. J. Natl. Cancer Inst., 18:769-778,1957.
2. Herberman, R. B. Counterpoint: Animal tumor models and their relevance to human tumor immunology. J. Biol. Response Modif., 2:39-46,1983.
3. Rosenberg, S. A., and Terry, W. D. Passive immunotherapy of cancer in animals and man. Adv. Cancer Res., 25:323,1977.
4. Laucius, J. F., Bodurtha, A. J., Mastrangelo, M. J., and Bellet, R. E. A Phase II study of autologous irradiated tumor cells Plus BCG in Patients with metastatic malignant melanoma. Cancer (Phila.), 40:2091-2093,1977.
5. Berendt, M. J., and North, R. J. T cell-mediated suppression of antitumor immunity. An explanation for the Progressive growth of an immunogenic tumor. J. Exp. Med., 757:69-80, 1980.
6. Takei, F., Levy, J., and Kilbum, D. G. Characterization of suppressor cells in mice bearing syngeneic mastocytoma. J. Immunol., 118:412-417, 1977.
7. Fujimoto, S., Green, M. I., and Sehon, A. H. Regulation of the immune response to tumor antigens. I. Immunosuppressor cells in tumor-bearing hosts. J. Immunol., 116:791-799, 1976.
8. Dye, E. S., and North, R. J. T cell-mediated immunosuppression as an obstacle to adoptive immunotherapy of the P81S mastocytoma and its metastases. J. Exp. Med., 154:1033-1042, 1981.
9. Rosenstein, M., Eberlein, T. J., and Rosenberg, S. A. Adoptive immunotherapy of established syngeneic solid tumors: Role of T lymphoid subpopulations. J. Immunol., 132:2117-2122, 1984.
10. North, R. J. Cyclophosphamide-facilitated adoptive immunotherapy of an established tumor depends on elimination of tumor-induced suppressor T cells. J. Exp. Med., 55:1063-1074,1982.
11. Maguire, H. C., Jr., and Ettore, V. L. Enhancement of dinitrochlorobenzene (DNCB) contact sensitization by cyclophosphamide in the guinea Pig. J. Invest. Dermatol., 48:39-42,1967.
12. Berd, D., Mastrangelo, M. J., Engstrom, P. F., Paul, A., and Maguire, H. C. Augmentation of the human immune response by cyclophosphamide. Cancer Res., 42:4862-4866,1982.
13. Berd, D., Maguire, H. C., Jr., and Mastrangelo, M. J. Potentiation of human cell-medited and humoral immunity by low-dose cyclophosphamide. Cancer Res., 44: 5439-5443,1984.
14. Peters, L. C., Brandhorst, J. S., and Hanna, M. G. Preparation of immuno- therapeutic autologous tumor cell vaccines from solid tumors. Cancer Res., 39:1353-1360, 1979.
15. Hoover, H. C., Jr., Surdyke, M., Dangel, R. B., Peters, L. C., and Hanna, M. G., Jr. Delayed cutaneous hypersensitivity to autologous tumor cells in colorectal cancer Patients immunized with an autologous tumor cell: Bacillus Calmette-Guerin vaccine. Cancer Res., 44: 1671-1676, 1984.
16. Bumol, T. F., and Reisfeld, R. A. Unique glycoprotein-proteoglycan complex defined by monoclonal antibody on human melanoma cells. Proc. Natl. Acad. Sci. USA, 79:1245-1249, 1982.
17. McCune, C. S., Schapira, D. V., and Henshaw, E. C. Specific immunotherapy of advanced renal carcinoma: Evidence for the Polyclonality of metastases. Cancer (Phila.), 47:1984-1987,1981.
18. Tykkä, H., Hjelt, L., Oravisto, K. J., Turunen, M., and Tallberg, T. Disappearance of lung metastases during immunotherapy in five Patients suffering from renal carcinoma. Scand. J. Resp. Dis., 89 (Suppl.): 123-134, 1974.
19. Hoover, H. C., Jr., Surdyke, M. G., Dangel, R. B., Peters, L. C., and Hanna, M. G., Jr. Prospectively randomized trial of adjuvant active-specific immunotherapy for human colorectal cancer. Cancer (Phila.), 55: 1236-1243, 1985.